Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunityEmma C. Thomson, Massimo Galli, Gyorgy Snell et al.|Cell|2021Cited by 656
Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activityLeslie W. Tari, John Finn, Michael Trzoss et al.|Bioorganic & Medicinal Chemistry Letters|2012Cited by 118
Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial AgentsLeslie W. Tari, John Finn, Xiaoming Li et al.|PLoS ONE|2013Cited by 104
Structural basis for the inhibition of Aurora A kinase by a novel class of high affinity disubstituted pyrimidine inhibitorsLeslie W. Tari, Ronald V. Swanson, Isaac Hoffman et al.|Bioorganic & Medicinal Chemistry Letters|2006Cited by 37
Structure of MurA (UDP-<i>N</i>-acetylglucosamine enolpyruvyl transferase) from<i>Vibrio fischeri</i>in complex with substrate UDP-<i>N</i>-acetylglucosamine and the drug fosfomycinDaniel C. Bensen, L.W. Tari, Sergio E. Rodriguez et al.|Acta Crystallographica Section F Structural Biology and Crystallization Communications|2012Cited by 22